Saibal Mukherjee is a senior legal and policy leader working at the intersection of AI, data, digital health, and technology regulation. He advises on the EU AI Act, GDPR, cybersecurity, and medical device requirements, with a focus on compliant deployment at scale. He has supported the design and rollout of 200+ AI-enabled digital health solutions and Software as a Medical Device (SaMD) offerings, and leads NIS2 compliance across all 27 EU member states. He also oversees legal matters for Takeda’s Global Capability Centers in India, Slovakia, Mexico, China, and Japan.

Earlier in his career, during India’s liberalization, Saibal supported market entry for multiple Fortune 500 companies, secured regulatory approvals for laying optical fiber across Delhi, and helped enable Bharti’s mobile rollout across several Indian cities. While negotiating telecom infrastructure and network tower agreements with Nokia, Ericsson, and Motorola, he developed a pay-per-subscriber usage model that Ericsson later adopted globally.

Saibal served as General Counsel for Novartis in India, leading the setup of the offshoring center in Hyderabad, and later moved to Novartis’ global headquarters in Basel, where he worked on global M&A and served as global oncology counsel. At Stryker, he managed the relocation of the regional headquarters from Switzerland to the Netherlands, oversaw market exits in 50+ countries, designed global distribution network frameworks, and supported acquisitions across China, the United States, and Europe.

He remains active in public policy through industry chambers and is a regular speaker on AI governance, cybersecurity, and digital health law. Outside work, he writes and guest lectures on technology law topics.